Correlation Between Moderna and Novavax

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Moderna and Novavax at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Moderna and Novavax into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Moderna and Novavax, you can compare the effects of market volatilities on Moderna and Novavax and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Moderna with a short position of Novavax. Check out your portfolio center. Please also check ongoing floating volatility patterns of Moderna and Novavax.

Diversification Opportunities for Moderna and Novavax

0.69
  Correlation Coefficient

Poor diversification

The 3 months correlation between Moderna and Novavax is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Moderna and Novavax in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novavax and Moderna is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Moderna are associated (or correlated) with Novavax. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novavax has no effect on the direction of Moderna i.e., Moderna and Novavax go up and down completely randomly.

Pair Corralation between Moderna and Novavax

Assuming the 90 days horizon Moderna is expected to under-perform the Novavax. But the stock apears to be less risky and, when comparing its historical volatility, Moderna is 2.17 times less risky than Novavax. The stock trades about -0.06 of its potential returns per unit of risk. The Novavax is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  1,661  in Novavax on August 25, 2024 and sell it today you would lose (841.00) from holding Novavax or give up 50.63% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Moderna  vs.  Novavax

 Performance 
       Timeline  
Moderna 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Moderna has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Novavax 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Novavax has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Moderna and Novavax Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Moderna and Novavax

The main advantage of trading using opposite Moderna and Novavax positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Moderna position performs unexpectedly, Novavax can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novavax will offset losses from the drop in Novavax's long position.
The idea behind Moderna and Novavax pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets